Navigation Links
STC-Stem Cell Treatment & Research Institute Registers Local Patent for Method to Mass Produce Pluripotent Stem Cells Without Side Effects

SEOUL, South Korea, Feb. 29, 2016 /PRNewswire/ -- STC-Stem Cell Treatment & Research Institute ("STRI" or "the Company") Chairman Kye-ho Lee announced the Company's registration of a local patent on the method to mass produce its pluripotent stem cells without side effects. The Company plans to follow the patent application and registration process in 146 different countries.

The patented technology uses latest cell differentiation and cultivation technology, along with low molecular weight compound extracted from a natural compound. This enables the mass production of a mesenchymal stem cell and pluripotent stem cells without side effects.

"Using mesenchymal stem cells as source and treating them with a low molecular weight compound derived from a natural compound, we were able to discover a pluripotent stem cell without side effects. Its significance lies in being able to mass produce such pluripotent stem cells without side effects while continuing to maintain its functionality," remarked Dr. Alex Lee from STRI. He added, "This technology will enable us to discover a more efficient and economic means of cell therapy."

Such mass production will be available not only for the pluripotent stem cell itself but also for its derived cells, including the pancreatic beta cell, hepatocyte, neurocyte, chondrocyte and osteoblast. This discovery offers a whole new paradigm in the field of cell therapy that is not only effective but also highly approachable.

Chairman Kye-ho Lee of STRI remarked, "The significance of the patented technology lies in it overcoming the limitations faced by research & development that uses conventional Induced Pluripotent Stem Cell (iPSC) technology and is expected to bring a whole new dimension to cell therapy development."

For further information, please contact:

Kris Yoon
Tel: +82-2-3438-0613

Copyright©2016 PR Newswire.
All rights reserved

Related biology technology :

1. IntelliCyt and FIMM Announce a Collaboration to Advance Personalized Medicine in Cancer Treatment
2. At University Of Maryland, First Cancer Patients Receive Proton Therapy at New Maryland Proton Treatment Center
3. Pharnext Supports the Fight Against Rare Diseases through Development of Pleotherapy-based Treatments
4. Regeneron Joins Human Vaccines Project to Improve Global Disease Prevention and Treatment
5. Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
6. Innovative Med Concepts Announces Receipt of FDA Fast Track Designation for IMC-1, a Novel Treatment for Fibromyalgia
7. RYNKL, a Tool for Evaluating the Effectiveness of Anti-Aging Skin Treatments, Receives Funding through Kickstarter, Launches on Android
8. Milestone Pharmaceuticals Announces USAN Approval of Generic Name "Etripamil" for its Phase 2 Clinical Development Product for the Treatment of Paroxysmal Supraventricular Tachycardia
9. Amniotic Biologic Treatment for Erectile Dysfunction Deemed "Game Changer"
10. Clinical Trial: Blockbuster Diabetes Treatment Not a Medication
11. Neurelis Initiates Pivotal Clinical Program for NRL-1 in the Treatment of Acute Repetitive Seizures
Post Your Comments:
(Date:5/9/2020)... ... 08, 2020 , ... Worldwide Business with kathy ireland® will be ... May 10, 2020 and Wednesday, May 13, 2020 at 8:00pm ET / PT – ... key executives from Techolution and Bravado Pharmaceuticals . , As ...
(Date:5/5/2020)... ... ... ProductLife Group has marked the next phase in its global growth ambitions ... Altran, where he was Group VP of Life Sciences and Head of Life Sciences ... involved in his early career in the development of new medical devices for the ...
(Date:5/1/2020)... ... April 30, 2020 , ... The winners of Fast ... projects, and concepts that are actively engaged and deeply committed to changing the ... taken out the top prize in the Experimental category. , The RASTRUM™ 3D ...
(Date:4/23/2020)... NEWS, Va. (PRWEB) , ... April 22, 2020 ... ... of essential equipment for healthcare providers to protect themselves from COVID-19. Virginia has ... requests from the Federal Emergency Management Association (FEMA). , As Governor Northam told ...
Breaking Biology Technology:
(Date:5/14/2020)... (PRWEB) , ... May 12, ... ... – a platform that helps Life Science Manufacturers accurately and easily project ... automating the development of Gross-to-Net models by projecting discounts/rebates to Commercial and ...
(Date:5/11/2020)... ... May 11, 2020 , ... Octagos ... for patients with implanted cardiac devices. The Octagos software allows healthcare professionals access ... software greatly simplifies the management of remote transmissions and at the same time ...
(Date:5/1/2020)... ... 30, 2020 , ... USARAD Holdings Inc., the leading US ... firms announces an official launch of In an effort to help the ... by offering live video consultations with board certified physicians in all specialties in ...
Breaking Biology News(10 mins):